https://www.selleckchem.com/pr....oducts/lixisenatide.
The clinical course of these tumors and the reason for their occurrence in this location are not known.Objective To assess amyotrophic lateral sclerosis (ALS) prevalence and to analyze how this estimate vary according to the historical depth of data collection. Methods Data from the PARALS register have been used. Crude prevalence ratio was estimated on 31 December 2015 for the period 2015-2013 and then repeated extending the time interval by 3 years each time. For each time interval, prevalence ratio was calculated globally and st
Like
Comment
Share
